Autopsy report · NCT00503698
The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis
Cause of deathNo reason given
“See termination reason in detailed description”
Life of this trial
- Ran for about 1 year 5 months before it stopped.
- 712 participants enrolled.
- Results were posted on the registry 1 year 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Novo Nordisk A/S
- Sponsor type
- Industry
- Conditions
- Chronic Kidney Disease; End-Stage Renal Disease
- Interventions
- somatropin; placebo
- Participants
- 712
- Sites
- 381
- Countries
- Argentina, Brazil, Canada, China, Denmark, France, Germany, Hungary, India, Israel, Italy, Poland and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.